In reaction to disappointing earnings/guidance:
- QADA -13.7%, ZOES -10.5%, GME -7%, SPLK -5.1%
- SPI -12.4% (modestly pulling back)
- TPIC -9.1% (TPI Composites was notified by General Electric International, Inc. (GE) that GE does not intend to extend its supply agreement)
- TRIL -7.3% (commences offering of its common shares and Series II Non-Voting Convertible First Preferred Shares)
- TRGP -4.5% (prices 17 mln shares of common stock at $46.10 per share)
- CGIX -3.8% (files for $100 mln mixed securities shelf offering)
- HGV -2.3% (Hilton Grand Vacations files for 15,008,689 share common stock offering by the selling stockholders)
- JKS -5.9% (downgraded to Underweight at Morgan Stanley; to Sell at Citi)
- SHPG -2.2% (downgraded to Mkt Perform from Outperform at Bernstein)
- TRIP -1.2% (downgraded to Underperform from Neutral at Macquarie)
- E -1% (downgraded to Underperform from Neutral at Exane BNP Paribas)
In reaction to strong earnings/guidance:
- NTNX +16.8%, DECK +12.3%, BIG +8.2%, EGHT +6.8%, VEEV +5.8%, TOUR +4.8%, LGF.A +3.7%, ULTA +2.7%, COST +1.7%, CAL +1.3%, FND +0.9%,VNET +0.9%
- AFSI +8.4% (will issue common equity to raise gross proceeds of $300 million through a private placement with members of the Karfunkel family)
- BIG +8.2% (following COST earnings and ahead of its own earnings release)
- SQNS +5.3% (extending this afternoon's move higher)
- CLNE +3.4% (awarded a renewable natural gas (RNG) contract)
- MTDR +2.7% (will replace Western Refining in the S&P MidCap 40)
- CDXC +2.2% (announced the closing of the $16.4 million second tranche of the strategic investment of up to $25 million led by Hong Kong business leader Mr. Li Ka-shing)
- AERI +1.9% (prices $75 mln (upsized from $50 mln) common stock offering at $53.75/share)
- ICPT +1.8% ( announces that Health Canada has granted a conditional approval for Ocaliva for the treatment of primary biliary cholangitis )
- MNK +1.1% (highlights first patients in company-sponsored prospective observational registry on the use of H.P. Acthar Gel following acute multiple sclerosis relapse)
- BBRY +0.7% (reaches agreement w/ Qualcomm (QCOM); arbitration panel has issued a final award providing for the payment by Qualcomm to BlackBerry of a total amount of $940 mln for calendar 2016 and 1Q17)
- NEWR +0.5% (featured on Thursday's Mad Money)
- INFN +3.5% (upgraded to Outperform from Market Perform at Wells Fargo)
- RRGB +1.4% (upgraded to Buy from Hold at Canaccord Genuity)
- NCLH +1% (upgraded to Outperform from Neutral at Wedbush)
- SINA will distribute one Weibo Class A ordinary share to the holder of each ten SINA ordinary shares. Holders of SINA ordinary shares that are settled through DTC will receive Class A ordinary shares represented by Weibo ADSs. The Weibo share distribution will be payable on or about July 10, 2017, to shareholders of record as of the close of business on June 7, 2017.
- Following the distribution of the Weibo shares, SINA's equity stake in Weibo will decrease from ~49% (or ~74% by voting power) currently to ~46% (or ~72% by voting power)
- During Q4FY2017, the company released a total of 5 films including 1 medium budget and 4 low budget films as compared to 6 medium and 6 low budget films in Q4FY2016.
Gapping down: QADA -13.7%, ZOES -10.8%, TPIC -9.1%, TRIL -7.3%, SPLK-5.4%, GME -5%, TRGP -4.5%, CGIX -3.8%, HGV -2.3%, NEWT -0.9%, TOUR -0.5%
* Is "Goldilocks" Back?
Yes. The confluence of an economy that looks poised to grow in 2017 at the Fed's 2.1% estimate (UBSe 2.2%) bolstered by a 2Q tracking near 4% while yields remain low, employment strong and energy prices anchored within a range around $50/bbl. have created ideal conditions for consumers and businesses alike, resulting in all-time highs in the S&P 500 and all-time lows in market volatility (Figure 1).
* Sell (Vol) in May and Go Away?
No. Volatility, VIX, by its very nature is mean reverting, with a long run average of around 19. While we cannot know the timing and the nature of the next period of higher volatility, historically inexpensive option prices make attractive limited risk/theoretically unlimited reward stock replacement strategies as well as portfolio hedges to protect against the 5-10% corrections which have occurred regularly over the past three years.
* Tech – Party Like It's 1999?
For now. Technology continues to be an overweight UBS Strategy sector whose valuation is not yet near prior extremes on an absolute or a relative basis. Nevertheless, such concentrated outperformance by a handful of stocks amid signs of crowded positioning is cause for concern coming into a time of year where reduced liquidity has exerted pressure on "consensus trades."
* What is the "Sum of No Fears"?
Can the economy, earnings and markets remain not too hot, not too cold, but just right? What are the current concerns which, typically overcome, have propelled stocks higher these past eight years? Valuations, market "internals," surprises, and the shape of the yield curve figure prominently in a list of investor preoccupations.